Efficacy and safety of rituximab in B-cell post-transplant lymphoproliferative disorders: results of a prospective multicentre phase II study

Sylvain Choquet, Veronique Leblond, Raoul Herbrecht, Gerard Socie, Anne-marie Stoppa, Peter Vandenberghe, Alain Fischer, Franck Morschhauser, Gilles Salles, Walter Feremans, Etienne Vilmer, Marie-Noel Peraldi, Philippe Lang, Yvon Lebranchu, Eric Oksenhendler, Jeanne-Luce Garnier, Thierry Lamy, Arnaud Jaccard, Augustin Ferrant, Fritz Offner, Olivier Hermine, Anne Moreau, Samira Fafi-Kremer, Patrice Morand, Lucienne Chatenoud, Nathalie Berriot-Varoqueaux, Loic Bergougnoux and Noel Milpied

This is a PDF-only article. The first page of the PDF of this article appears below.

PDF extract preview